Author

Leo Pavliv

Observed names: L Pavliv, Pavliv, Leo

Observed institution: Cumberland Pharmaceuticals (United States)

OpenAlex ID: A5001038485

A multicenter, randomized, double-blind, placebo- controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain

2009 · Stephen Southworth, Jeannine Peters, et al. · Clinical Therapeutics · 139

A Multi-Center, Randomized, Double-Blind Placebo-Controlled Trial of Intravenous-Ibuprofen (IV-Ibuprofen) for Treatment of Pain in Post-Operative Orthopedic Adult Patients

2010 · Neil Singla, Amy Rock, et al. · Pain Medicine · 93

A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial of Intravenous Ibuprofen (IV‐Ibuprofen) in the Management of Postoperative Pain Following Abdominal Hysterectomy

2010 · Peter B. Kroll, Laura Meadows, et al. · Pain Practice · 84

Pharmacokinetics, safety, and tolerability of a rapid infusion of i.v. ibuprofen in healthy adults

2010 · Leo Pavliv, Bryan Voss, et al. · American Journal of Health-System Pharmacy · 49

Fewer adverse effects associated with a modified two-bag intravenous acetylcysteine protocol compared to traditional three-bag regimen in paracetamol overdose

2018 · Lars E. Schmidt, Ditlev N. Rasmussen, et al. · Clinical Toxicology · 39

Antagonism of the Thromboxane‐Prostanoid Receptor is Cardioprotective against Right Ventricular Pressure Overload

2016 · James D. West, Bryan M. Voss, et al. · Pulmonary Circulation · 32

A Prospective, Multicenter, Randomized, Double-Blind Trial of IV Ibuprofen for Treatment of Fever and Pain in Burn Patients

2010 · John T. Promes, Karen Safcsak, et al. · Journal of Burn Care & Research · 24

Antagonism of the Thromboxane‐Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy

2019 · James D. West, Cristi L. Galindo, et al. · Journal of the American Heart Association · 20

Intravenous Ibuprofen Reduces Opioid Consumption During the Initial 48 Hours After Injury in Orthopedic Trauma Patients

2020 · Russell D. Weisz, Alexander A. Fokin, et al. · Journal of Orthopaedic Trauma · 19

Pharmacokinetics of conivaptan use in patients with severe hepatic impairment

2017 · Thomas Marbury, Jerry Fox, et al. · Drug Design Development and Therapy · 10

Formulation and Manufacturing

2007 · Leo Pavliv, James F. Cahill · Springer eBooks · 6

Topical formulation development of a novel thymidylate synthase inhibitor for the treatment of psoriasis

1994 · Leo Pavliv, Ken Freebern, et al. · International Journal of Pharmaceutics · 4

Abstract 94: Randomized, Double-blind, Placebo-controlled Phase 1 Study Of Vwf-binding Aptamer, Bb-031: Safety, Tolerability, Pharmacokinetic And Pharmacodynamic Activity In Healthy Volunteers

2023 · Shahid M Nimjee, Debra Wheeler, et al. · Stroke · 3

Liposomal formulations of a novel antitumor agent: drug loading and optimization.

1995 · L Pavliv, P Tyle, et al. · PubMed · 2

Abstract Number: Esoc2026ot73 Bb-031 in Acute Treatment: Safety, Tolerability, Pharmacokinetics (pk) and Pharmacodynamics (pd) in Acute Ischemic Stroke – the Raise Trial

2026 · Shahid Nimjee, Leo Pavliv, et al. · European Stroke Journal · 1

Abstract 397: Preventing Cardiomyopathy of Muscular Dystrophy Through Antagonism of the Thromboxane/Prostanoid Receptor

2018 · Erica J Carrier, Cristi L Galindo, et al. · Circulation Research

Guidelines for Selecting Sustained-Release Technology

2000 · Praveen Tyle, Ge Chen, et al. · CRC Press eBooks

Works count: 19

Citation count: 525

H-index: 10

I10-index: 10